Becton, Dickinson and CompanyBDX
NYSE • Healthcare
$154.22
P/E
25.21
PEG
0.15
FCF Yield
—
Rev Growth YoY
+622.0% YoY
Gross Margin
4642.0%
Health Score
5/10
D/E Ratio
0.76
Confidence
LOW
Business Snapshot
Becton, Dickinson and Company (BDX) is a large-cap global medical technology company that manufactures and sells a broad range of medical devices, instruments, reagents, and diagnostic systems across hospitals, clinical laboratories, and life sciences settings worldwide. The company operates across segments including BD Medical, BD Life Sciences, and BD Interventional, serving healthcare providers across more than 190 countries. Based on its price and valuation multiples, BDX sits firmly in the large-cap healthcare tier, though a precise market capitalisation figure is unavailable in this dataset.
Financial Health
**Score: 5/10** BDX carries a Debt/Equity ratio of 0.76x, which is broadly manageable and not a red flag on its own. However, the reported gross margin of 4,642% and net margin of 801% are almost certainly the result of a data anomaly — figures at this scale are not operationally plausible for a medical devices manufacturer and cannot be relied upon for margin analysis...
Risk Assessment
- **DATA INTEGRITY: Gross margin of 4,642% and net margin of 801% are not plausible for a medical devices manufacturer and indicate corrupted or misrepresented financial inputs in this dataset.** - **TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is a bearish structural signal; the MACD is also bearish, and the current price of $154.22 sits below both moving averages.** - **VALUATION ANCHOR: Both DCF models return N/A, leaving no independent fair-value estimate to assess whether $154.22 represents a discount or premium to intrinsic value.** - **PRICE PRESSURE: BDX is trading 17.6% below its 52-week high of $187.35, consistent with sustained distribution or negative momentum in the stock.** - **CASH FLOW OPACITY: Free cash flow and FCF yield are both unavailable, making it impossible to assess capital generation quality or dividend sustainability.** ---...